Molecular Predictors in Glioblastoma : Toward Personalized TherapyCOLMAN, Howard; ALDAPE, Ken.Archives of neurology (Chicago). 2008, Vol 65, Num 7, pp 877-883, issn 0003-9942, 7 p.Article

Isolation and Perivascular Localization of Mesenchymal Stem Cells From Mouse BrainKANG, Seok-Gu; SHINOJIMA, Naoki; HOSSAIN, Anwar et al.Neurosurgery. 2010, Vol 67, Num 3, pp 711-720, issn 0148-396X, 10 p.Article

Graph Clustering Techniques Applied to the Glycomic Response in Glioblastoma Cells to Treatments with STAT3 Phosphorylation Inhibition and Fetal Bovine SerumGÖRKE, Robert; MEYER-BASE, Anke; PLANT, Claudia et al.Proceedings of SPIE, the International Society for Optical Engineering. 2011, Vol 8059, issn 0277-786X, isbn 978-0-8194-8633-2, 80590I.1-80590I.12Conference Paper

Novel HSP90 Inhibitor NVP-HSP990 Targets Cell-Cycle Regulators to Ablate Olig2-Positive Glioma Tumor―Initiating CellsJUN FU; KOUL, Dimpy; JUN YAO et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 10, pp 3062-3074, issn 0008-5472, 13 p.Article

Phase 1/1b Study of Lonafarnib and Temozolomide in Patients With Recurrent or Temozolomide Refractory GlioblastomaYUST-KATZ, Shlomit; LIU, Diane; HSU, Sigmonid et al.Cancer. 2013, Vol 119, Num 15, pp 2747-2753, issn 0008-543X, 7 p.Article

The prognostic impact of histology and 1p/19q status in anaplastic oligodendroglial tumorsMCDONALD, J. Matthew; SIEW JU SEE; PASSE, Sandra et al.Cancer. 2005, Vol 104, Num 7, pp 1468-1477, issn 0008-543X, 10 p.Article

Phase 2 Trial of Irinotecan and Thalidomide in Adults With Recurrent Anaplastic GliomaGIGLIO, Pierre; DHAMNE, Megha; CONRAD, Charles A et al.Cancer. 2012, Vol 118, Num 14, pp 3599-3606, issn 0008-543X, 8 p.Article

Assessment and prognostic significance of mitotic index using the mitosis marker phospho-histone H3 in low and intermediate-grade infiltrating astrocytomasCOLMAN, Howard; GIANNINI, Caterina; BURGER, Peter et al.The American journal of surgical pathology. 2006, Vol 30, Num 5, pp 657-664, issn 0147-5185, 8 p.Article

YKL-40 expression is associated with poorer response to radiation and shorter overall survival in glioblastomaPELLOSKI, Christopher E; MAHAJAN, Anita; PASSE, Sandra et al.Clinical cancer research. 2005, Vol 11, Num 9, pp 3326-3334, issn 1078-0432, 9 p.Article

Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastomaPELLOSKI, Christopher E; BALLMAN, Karla V; WOO, Shiao Y et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2288-2294, issn 0732-183X, 7 p.Article

Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastomaNIGRO, Janice M; MISRA, Anjan; YUNG, W. K et al.Cancer research (Baltimore). 2005, Vol 65, Num 5, pp 1678-1686, issn 0008-5472, 9 p.Article

A Randomized Trial of Bevacizumab for Newly Diagnosed GlioblastomaGILBERT, Mark R; DIGNAM, James J; JERAJ, Robert et al.The New England journal of medicine. 2014, Vol 370, Num 8, pp 699-708, issn 0028-4793, 10 p.Article

The transcriptional network for mesenchymal transformation of brain tumoursCARRO, Maria Stella; KEAT LIM, Wei; LASORELLA, Anna et al.Nature (London). 2010, Vol 463, Num 7279, pp 318-325, issn 0028-0836, 8 p.Article

Examination of the therapeutic potential of delta-24-RGD in brain tumor stem cells : Role of autophagic cell deathHONG JIANG; GOMEZ-MANZANO, Candelaria; LANG, Frederick F et al.Journal of the National Cancer Institute. 2007, Vol 99, Num 18, pp 1410-1414, issn 0027-8874, 5 p.Article